<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Radiomics-Integrated Deep Learning with Hierarchical Loss for Osteosarcoma Histology Classification - Health AI Hub</title>
    <meta name="description" content="This paper introduces two novel approaches to enhance deep learning models for osteosarcoma histology classification: integrating radiomic features as multimoda">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Radiomics-Integrated Deep Learning with Hierarchical Loss for Osteosarcoma Histology Classification</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.09416v1" target="_blank">2601.09416v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-14
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Yaxi Chen, Zi Ye, Shaheer U. Saeed, Oliver Yu, Simin Ni, Jie Huang, Yipeng Hu
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.09416v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.09416v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces two novel approaches to enhance deep learning models for osteosarcoma histology classification: integrating radiomic features as multimodal input and employing a hierarchical loss function for two binary tasks (tumor vs. non-tumor, viable vs. non-viable). These methods collectively address the challenge of poor patient-level generalization observed in prior studies. The proposed techniques significantly improve classification performance on the TCIA OS Tumor Assessment dataset, establishing a new state-of-the-art for automated osteosarcoma viability assessment.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate, consistent, and automated quantification of osteosarcoma tumor viability post-neoadjuvant chemotherapy is paramount for guiding treatment decisions, predicting patient prognosis, and reducing the inherent subjectivity and variability of manual pathology assessments.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application involves using radiomics-integrated deep learning with a hierarchical loss function to automatically classify osteosarcoma histology (viable vs. non-viable tumor regions) from digital pathology images. This assists clinicians in making more accurate and consistent assessments for patient prognosis and individualized treatment planning following neoadjuvant chemotherapy.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses the critical need for accurate, automated histopathological assessment of osteosarcoma (OS) tumor viability after neoadjuvant chemotherapy, overcoming issues of manual subjectivity and labor.</li>
                    
                    <li>Identifies a significant challenge in existing deep learning models where performance drops considerably during generalization from tile-level to patient-level data.</li>
                    
                    <li>Proposes the integration of radiomic features as an additional, multimodal input to deep learning models, demonstrating improved classification performance and enhanced interpretability.</li>
                    
                    <li>Introduces a novel hierarchical loss function, which reframes the classification into two binary tasks: 'tumor-vs-non-tumor' and 'viable-vs-non-viable,' rather than a single 'flat' three-class classification.</li>
                    
                    <li>The hierarchical loss function incorporates trainable weightings between these two interconnected tasks, leading to significant improvements in per-class classification performance.</li>
                    
                    <li>Experimentally validates the benefits of both radiomics integration and the hierarchical loss function, individually and in combination, using the open TCIA OS Tumor Assessment dataset.</li>
                    
                    <li>Claims to achieve a new state-of-the-art performance for osteosarcoma histology classification on the specified open dataset, effectively improving patient-level generalization.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs deep learning models for analyzing digital pathology images. Its core methodological innovations include: 1) incorporating radiomic features, extracted from the images, as a multimodal input alongside the raw image data; and 2) utilizing a novel hierarchical loss function. This hierarchical loss optimizes two interdependent binary classification tasks (tumor vs. non-tumor, and viable vs. non-viable) with trainable weighting parameters, as an alternative to a single 'flat' three-class classification. The TCIA OS Tumor Assessment dataset was used for model training and evaluation.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>['Integrating radiomic features as additional multimodal input significantly improves osteosarcoma histology classification performance and enhances model interpretability.', "Optimizing with a hierarchical loss function, structured around two binary classification tasks (tumor-vs-non-tumor, viable-vs-non-viable) with trainable weights, substantially improves per-class performance compared to a single 'flat' three-class approach.", 'The proposed methods effectively address the challenge of decreased patient-level generalization ability observed in previous deep learning models for this application.', 'The combination of radiomics integration and hierarchical loss achieves a new state-of-the-art performance on the TCIA OS Tumor Assessment dataset for osteosarcoma histology classification.']</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research offers a robust, automated, and objective tool that could significantly improve the clinical workflow for osteosarcoma patients. By providing more accurate and consistent assessments of tumor viability after chemotherapy, it can lead to more precise prognostic predictions, better-informed treatment planning, and potentially facilitate more personalized medicine approaches, while reducing the burden and variability associated with manual pathological evaluations.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations of the proposed methods. However, it highlights that the work addresses a significant limitation of prior deep learning studies: the performance drop from tile-level to patient-level generalization.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>Future research directions are not explicitly mentioned in the abstract.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Orthopedic Surgery</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">osteosarcoma</span>
                    
                    <span class="tag tag-keyword">histology classification</span>
                    
                    <span class="tag tag-keyword">deep learning</span>
                    
                    <span class="tag tag-keyword">radiomics</span>
                    
                    <span class="tag tag-keyword">hierarchical loss</span>
                    
                    <span class="tag tag-keyword">neoadjuvant chemotherapy</span>
                    
                    <span class="tag tag-keyword">tumor viability</span>
                    
                    <span class="tag tag-keyword">digital pathology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Osteosarcoma (OS) is an aggressive primary bone malignancy. Accurate histopathological assessment of viable versus non-viable tumor regions after neoadjuvant chemotherapy is critical for prognosis and treatment planning, yet manual evaluation remains labor-intensive, subjective, and prone to inter-observer variability. Recent advances in digital pathology have enabled automated necrosis quantification. Evaluating on test data, independently sampled on patient-level, revealed that the deep learning model performance dropped significantly from the tile-level generalization ability reported in previous studies. First, this work proposes the use of radiomic features as additional input in model training. We show that, despite that they are derived from the images, such a multimodal input effectively improved the classification performance, in addition to its added benefits in interpretability. Second, this work proposes to optimize two binary classification tasks with hierarchical classes (i.e. tumor-vs-non-tumor and viable-vs-non-viable), as opposed to the alternative ``flat'' three-class classification task (i.e. non-tumor, non-viable tumor, viable tumor), thereby enabling a hierarchical loss. We show that such a hierarchical loss, with trainable weightings between the two tasks, the per-class performance can be improved significantly. Using the TCIA OS Tumor Assessment dataset, we experimentally demonstrate the benefits from each of the proposed new approaches and their combination, setting a what we consider new state-of-the-art performance on this open dataset for this application. Code and trained models: https://github.com/YaxiiC/RadiomicsOS.git.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>